Abstract
Background
A retrospective study was performed to determine whether preoperative quantitative ultrasound assessment could predict axillary lymph node metastases and prognosis in patients with breast cancer. We focused on the presence of a halo, which is one of the features of breast cancer on ultrasound and represents reflections from the invading margin around infiltrating malignancies.
Methods
We evaluated ultrasonography from 187 infiltrating breast carcinoma patients with tumors 5 cm or less in greatest dimension (Tl, T2). Using computer image analysis, the halo area (H) and the sum of the area of halo and internal echo (total tumor area (T)) were measured, and the ratio of halo to entire tumor (H/T, halo ratio) was calculated and compared with lymph node status and prognosis.
Results
The mean of the halo ratio was 0.38+-0.13. Using the value of 0.42 as a cut-off, the high halo ratio group had significantly worse prognoses for both overall and disease-free survival at 49 months in median follow-up (p>0.001 and p>0.0005, respectively). The specificity of a high halo ratio in the Tl classification for predicting axillary node metastasis was 83.1%, with a negative predictive value of 86.8%. In patients with tumors 1.0 cm or smaller, the negative predictive value was 100%. In a multivariate analysis, halo ratio was an independent predictor of disease-free survival of breast carcinoma patients (p=0.0232).
Conclusions
Preoperative quantitative ultrasound may be a useful non-invasive method for predicting the presence of axillary lymph node metastases and prognosis in patients with primary breast cancer.
Similar content being viewed by others
Abbreviations
- ER:
-
Estrogen receptor
- PR:
-
Progesterone receptor
References
Mendelson EB, Tobin CE: The breast. In: Goldberg B, Pettersson H, eds, Ultrasonography, The NICER Institute, Oslo, pp377–397, 1996.
Svensson WE: A review of the current status of breast ultrasound.European Journal of Ultrasound 6:77–101, 1997.
Fisher B, Bryant J, Wolmark N,et at: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.J Clin Oncol 16:2672–2685, 1998.
Silverstein MJ, Gierson ED, Waisman JR,et al: Axillary lymph node dissection for Tla breast carcinoma: Is it indicated?Cancer 73:664–667, 1994.
Kuznetsova M, Graybill JC, Zusag TW,et al: Omission of axillary lymph node dissection in early-stage breast cancer: Effect on treatment outcome.Radiology 197:507–510, 1995.
Wazer DE, Erban JK, Robert NJ,et al: Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection.Cancer 74:878–883, 1994.
Giuliano AE, Kirgan DM, Guenther JM,et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 220:391–401, 1994.
Giuliano AE, Dale PS, Turner RR,et al: Improved axillary staging of breast cancer with sentinel lympha- denectomy.Ann Surg 222:394–401, 1995.
Tohno E, Cosgrove DO, Sloane JP: Ultrasound Diagnosis of Breast Diseases. Churchill Livingstone, London, 1994.
Cole-Beuglet C, Soriano RZ, Kurtz AB,et al: Ultrasound analysis of 104 primary breast carcinomas classified according to histopathologic type.Radiology 147:191–196, 1983.
Onoiki J, Oshida M, Suzuki M,et al: The relationship between infiltrating grade and prognosis by the preoperative diagnosis in ultrasonogram in breast carcinoma.Nippon Geka Gakkai Zasshi 96:792–798, 1995.
Takehara Y, Hisada Y, Matsukawa M: Enhancement and significance of “halo” in the echogram of early breast cancer.J Med Ultrasonics 10:129–133, 1983.
Nagashima T, Suzuki M, Oshida M,et al: Morphometry in the cytologic evaluation of thyroid follicular lesions.Cancer 84:115–118, 1998.
Mobbs BG, Johnson IE: Use of enzyme immunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer.J Steroid Biochem 28:653–662, 1987.
Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer.Br J Cancer 11:359–377, 1957.
Bryan RM, Mercer RJ, Bennett RC,et al: Prognostic factors in breast cancer and the development of a prognostic index.BrJ Surg 73:267–271, 1986.
Barth A, Craig PH, Silverstein MJ: Predictors of axillary lymph node metastases in patients with Tl breast carcinoma.Cancer 79:1918–1922, 1997.
Weidner N, Semple JP, Welch WR,et al: Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma.N Engl J Med 324:1–8, 1991.
Horak ER, Leek R, Klenk N,et al: Angiogenesis, assessed by platelet/ endothelial cell adhesion mole- cule antibodies, as indicator of node metastases and survival in breast cancer.Lancet 340:1120–1124, 1992.
Gasparini G, Weidner N, Bevilacqua P,et al: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carci- noma.J Clin Oncol 12:454–466, 1994.
Roberti NE: The role of histologic grading in the prognosis of patients with carcinoma of the breast: Is this a neglected opportunity?Cancer 80:1708–1716, 1997.
Perrone F, Carlomagno C, Lauria R,et al: Selecting high-risk early breast cancer patients: What to add to the number of metastatic nodes?Eur J Cancer 32:41–46, 1996.
Mansour EG, Gray R, Shatila AH,et al: Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer.N Engl J Med 320:485–490, 1989.
Barsky SH, Rao CN, Grotendorst GR,et al: Increased content of type V collagen in desmoplasia of human breast carcinoma.Am J Pathol 108:276–283, 1982.
Marotta M, Martino G, D’Armiento FP,et al: Collagen in human breast cancer: Morphological and biochemical study.Appl Pathol 3:170–178, 1985.
Seemayer TA, Lagacé R, Schürch W,et al: Myofibro- blasts in the stroma of invasive and metastatic carcinoma: A possible host response to neoplasia.Am J Surg Pathol 3:525–533, 1979.
Lane N, Goksel H, Salerno RA,et al: Clinico-patho- logic analysis of the surgical curability of breast cancers: a minimum ten-year study of a personal series.Ann Surg 153:483–498, 1961.
de Freitas R, Costa MV, Schneider SV,et al: Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer.Eur J Surg Oncol 17:240–244, 1991.
Bruneton JN, Caramella E, Hery M,et al: Axillary lymph node metastases in breast cancer: Preoperative detection with US.Radiology 158:325–326, 1986.
Pamilo M, Soiva M, Lavast EM: Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients.J Ultrasound Med 8:115–120, 1989.
Tate JJT, Lewis V, Archer T,et al: Ultrasound detection of axillary lymph node metastases in breast cancer.Eur J Surg Oncol 15:139–141, 1989.
March DE, Wechsler RJ, Kurtz AB,et al: CT-patho- logic correlation of axillary lymph nodes in breast carcinoma.J Comput Assist Tontogr 15:440–444, 1991.
Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.Cancer 63:181–187, 1989.
Fisher B, Bauer M, Wickerham DL,et al: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update.Cancer 52:1551–1557, 1983.
Albrecht T, Patel N, Cosgrove DO,et al: Enhancement of power Doppler signals from breast lesions with the ultrasound contrast agent EchoGen emulsion: Subjective and quantitative assessment.Acad Radiol 5(suppl1):S195–198, 1998.
Huber S, Helbich T, Kettenbach J,et al: Effects of a microbubble contrast agent on breast tumors: Computer-assisted quantitative assessment with color Doppler US-early experience.Radiology 208:485–489, 1998.
Author information
Authors and Affiliations
About this article
Cite this article
Hashimoto, H., Suzuki, M., Oshida, M. et al. Quantitative ultrasound as a predictor of node metastases and prognosis in patients with breast cancer. Breast Cancer 7, 241–246 (2000). https://doi.org/10.1007/BF02967467
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02967467